Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jatinder Goyal
Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer
Clinical Medicine Insights: Urology
Related publications
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients With Metastatic Castration-Resistant Prostate Cancer
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
Abiraterone in Metastatic Castration-Resistant Prostate Cancer: Efficacy and Safety in Unselected Patients
Cancer Treatment and Research Communications
Cancer Research
Oncology
Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer
European Urology
Urology
Abiraterone Acetate for Early Stage Metastatic Prostate Cancer: Patient Selection and Special Considerations
Therapeutics and Clinical Risk Management
Expanding Horizons in Metastatic Prostate Cancer Treatment
Nature Reviews Clinical Oncology
Oncology
Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Apalutamide for the Treatment of Non‐metastatic Prostate Cancer
Prescriber
Pharmacology
A Prognostic Model for Stratifying Clinical Outcomes in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Canadian Urological Association Journal
Urology
